CTKB EBITDA Margin
Cytek Biosciences Inc · EBITDA Margin
CTKB EBITDA Margin
Latest reported-13.14%period ending
CTKB TTM EBITDA Margin (16.55% → -13.14%)
TTM ebitda margin
High-resolution chart · PNG
CTKB ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -13.1359% | |
| -10.8483% | |
| -7.9119% | |
| -9.2121% | |
| -5.5255% | |
| -6.1056% | |
| -5.0047% | |
| -0.3225% | |
| -2.4101% | |
| -1.9593% | |
| -2.2838% | |
| -2.5519% | |
| -0.2119% | |
| 2.0962% | |
| 5.3671% | |
| 2.4322% | |
| 2.1516% | |
| 5.0338% | |
| 6.9723% | |
| 13.1941% | |
| 18.2644% | |
| 16.763% | |
| 16.5512% |